Literature DB >> 26722560

Levels of hepatocyte growth factor in serum correlate with quality of life in hemodialysis patients.

Ewa Baum1, Krzysztof Pawlaczyk2, Beata Maćkowiak3, Patrycja Sosinska3, Monika Matecka3, Barbara Kolodziejczak3, Michał Musielak1, Andrzej Breborowicz4.   

Abstract

PURPOSE: Patients with end stage renal failure (ESRD) report low quality of life and inflammation may be one of the contributing factors. We studied if the hemodialysis induced inflammation correlates with the patients quality of life.
METHODS: Study was performed in 76 (35 males and 41 females) ESRD patients treated with hemodialysis. Effect of one dialysis session on blood concentration of Vascular Endothelial Growth Factor (VEGF), Hepatocyte Growth Factor (HGF), Interleukin 6 (IL6) and Monocyte Chemoattractant Protein-1 (MCP-1) was studied. Results were correlated with answers given by patients to a short questionnaire composed of questions from Kidney Disease Quality of Life Short Form (KDQoL-SF) questionnaire.
RESULTS: Hemodialysis induced increase of serum level of HGF (+117%) and IL-6 (+17%). Declared by patients health status correlated with their age, GFR, kt/V and hemodialysis induced change in serum IL6 and HGF level (R(2) = 0469, P < 0.001). Physical activity correlated with age, serum IL-6 and hemodialysis induced change in serum HGF and VEGF (R(2) = 0.362, P < 0.001). Presence of social/mental problems during previous 4 weeks correlated with age, serum HGF and hemodialysis induced changes in serum HGF and VEGF levels (R(2) = 0.333, P < 0.001). Interference of the kidney disease with daily life activities correlated with age, serum VEGF and hemodialysis induced change in serum HGF and IL6 levels (R(2) = 0.422, P < 0.001).
CONCLUSION: Inflammation correlates with reduced quality of life in ESRD. Low hemodialysis-induced release of the anti-inflammatory cytokine HGF correlates with impaired quality of life in that group of patients.

Entities:  

Keywords:  Uremia-hemodialysis; hepatocyte growth factor; inflammation; quality of life

Mesh:

Substances:

Year:  2015        PMID: 26722560      PMCID: PMC4680505     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Validation of the KDQOL-SF: a dialysis-targeted health measure.

Authors:  J C Korevaar; M P Merkus; M A M Jansen; F W Dekker; E W Boeschoten; R T Krediet
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

2.  Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor.

Authors:  T Rampino; E Arbustini; M Gregorini; P Guallini; C Libetta; M Maggio; A Ranghino; E Silini; G Soccio; A Dal Canton
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

Review 3.  Inflammation in end-stage renal disease--what have we learned in 10 years?

Authors:  Juan J Carrero; Peter Stenvinkel
Journal:  Semin Dial       Date:  2010 Sep-Oct       Impact factor: 3.455

Review 4.  Hepatocyte growth factor and the kidney.

Authors:  Youhua Liu
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-01       Impact factor: 2.894

5.  Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease.

Authors:  Michael S Katz; Keith A Thatch; Marshall Z Schwartz
Journal:  J Pediatr Surg       Date:  2012-01       Impact factor: 2.545

6.  Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study.

Authors:  Shuchi Anand; Glenn M Chertow; Kirsten L Johansen; Barbara Grimes; Manjula Kurella Tamura; Lorien S Dalrymple; George A Kaysen
Journal:  J Ren Nutr       Date:  2011-01-15       Impact factor: 3.655

7.  Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice.

Authors:  S Mizuno; K Matsumoto; T Kurosawa; Y Mizuno-Horikawa; T Nakamura
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

8.  Inflammatory signals associated with hemodialysis.

Authors:  Kayser Caglar; Youming Peng; Lara B Pupim; Paul J Flakoll; Deanna Levenhagen; Raymond M Hakim; T Alp Ikizler
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

9.  Acute kidney injury: effect of hemodialysis membrane on Hgf and recovery of renal function.

Authors:  Carmelo Libetta; Pasquale Esposito; Vincenzo Sepe; Teresa Rampino; Manuela Zucchi; Michele Canevari; Antonio Dal Canton
Journal:  Clin Biochem       Date:  2012-10-22       Impact factor: 3.281

10.  Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment.

Authors:  Agneta A Pagels; Birgitta Klang Söderkvist; Charlotte Medin; Britta Hylander; Susanne Heiwe
Journal:  Health Qual Life Outcomes       Date:  2012-06-18       Impact factor: 3.186

View more
  3 in total

1.  Long-term mortality and quality of life after trauma: an ancillary study from the prospective multicenter trial FROG-ICU.

Authors:  Bruno Pastene; Raphaël Cinotti; Etienne Gayat; Jacques Duranteau; Qin Lu; Philippe Montravers; Sébastien Pili-Floury; Isabelle Rennuit; Alexandre Mebazaa; Marc Leone
Journal:  Eur J Trauma Emerg Surg       Date:  2019-06-18       Impact factor: 3.693

Review 2.  Quality of the Healthcare Services During COVID-19 Pandemic in Selected European Countries.

Authors:  Magdalena Tuczyńska; Rafał Staszewski; Maja Matthews-Kozanecka; Agnieszka Żok; Ewa Baum
Journal:  Front Public Health       Date:  2022-05-12

3.  Comparison of high-flux hemodialysis with hemodialysis filtration in treatment of uraemic pruritus: a randomized controlled trial.

Authors:  Xia Jiang; Fen Ji; Zhi-Wei Chen; Qiao-Lin Huang
Journal:  Int Urol Nephrol       Date:  2016-07-05       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.